Invertase Market

Invertase Market Size, Market Forecast and Outlook By FMI

In 2025, the invertase market was valued at USD 65.2 million. Based on Future Market Insights' analysis, demand for invertase is estimated to grow to USD 67.9 million in 2026 and USD 101.4 million by 2036. FMI projects a CAGR of 4.1% during the forecast period.

Absolute dollar growth of USD 33.5 million over the decade reflects expanding invertase adoption beyond the traditional confectionery soft-center application into pharmaceutical taste masking, bakery moisture management, and sugar reduction formulation systems. Kerry Group's February 2026 announcement of a breakthrough enzyme system within its Tastesense sweet reduction technologies, using fermentation-derived enzymes to preserve taste profiles while reducing sugar content, directly positions invertase as a component in the next-generation sugar reduction portfolio targeting cocoa and sugar price volatility in confectionery and bakery markets. [3]

As Atsuya Hirano, Vice President at Amano Enzyme USA, noted regarding specialty enzyme applications at SupplySide Global 2025, 'Our enzymes help manufacturers precisely control key formulation properties such as sweetness, texture and functionality to meet the high standards expected of today's plant-based and dairy alternative products.' [2]

Summary of Invertase Market

• Invertase Market Definition
  • The market covers globally traded microorganism-based and plant-based invertase in food-grade and pharmaceutical-grade specifications, serving soft-center confectionery production, bakery moisture management, sugar reduction formulation systems, pharmaceutical taste modification, and personal care humectant applications.
• Demand Drivers in the Market
  • Kerry Group's February 2026 launch of a breakthrough fermentation-derived enzyme system within Tastesense sweet reduction technologies, targeting cocoa and sugar price volatility in confectionery and bakery markets where invertase provides moisture retention and texture management alongside sweetness modulation. [3]
  • Novonesis's February 2025 acquisition of the DSM-Firmenich feed enzyme alliance stake, unifying industrial enzyme distribution and innovation capacity to improve responsiveness for specialty enzyme categories including invertase across food and pharmaceutical application segments. [1]
  • BASF and IFF's October 2025 strategic partnership for the Designed Enzymatic Biomaterials platform, advancing protein-engineered enzyme technologies at commercial scale that will progressively improve invertase thermostability and pH tolerance profiles for expanded food processing applications. [2]
• Key Segments Analyzed in the FMI Report
  • Source: Microorganism-based invertase holds 56.2% of source share in 2026, reflecting the commercial scalability of Saccharomyces cerevisiae yeast fermentation for cost-effective food-grade enzyme production.
  • End-User: Food & Beverages accounts for 48.7% of total market value in 2026, anchored by confectionery soft-center applications and bakery moisture management systems.
  • Distribution Channel: Hypermarket/Supermarket accounts for 35.4% of channel value in 2026, consistent with commercial-scale ingredient procurement patterns for food and pharmaceutical buyers.
• Analyst Opinion at FMI
  • Nandini Roy Choudhury, Principal Consultant for Food & Beverageat Future Market Insights, opines, "In the updated version of the Invertase Market Report for 2026 to 2036, CXOs will find that invertase's traditional identity as a single-application confectionery enzyme understates its strategic value in an era of cocoa price spikes and regulatory sugar reduction pressure. My findings indicate that the integration of invertase into Kerry's Tastesense sugar reduction platform and the broader enzyme industry consolidation around Novonesis represent two converging forces: first, invertase will be bundled into multi-enzyme sugar management systems that command higher margin per application than standalone confectionery enzyme supply; second, pharmaceutical oral dosage taste masking demand will expand invertase's addressable market into a regulated-grade segment with significantly higher per-kilogram pricing than food-grade enzyme."
• Strategic Implications / Executive Takeaways
  • Pursue pharmaceutical-grade invertase certification to access the oral dosage form taste masking segment, where plant-based source certification and pharmacopoeia compliance create natural attrition among food-grade-only producers and support premium pricing.
  • Establish supply agreements with Novonesis as the post-merger industrial enzyme leader whose unified distribution infrastructure provides the broadest reach for specialty enzyme categories including invertase across food and pharmaceutical channels.
  • Position invertase as a component within multi-enzyme sugar reduction and texture management systems rather than as a standalone ingredient, aligning with Kerry's Tastesense bundled approach to capture higher formulation contract values.
• Methodology
  • Validated through primary interviews with yeast-derived enzyme producers and confectionery and bakery formulation specialists specifying invertase in soft-center and moisture management applications.
  • Supported by EU Regulation EC No 1332/2008 enzyme framework data, FDA GRAS notices for invertase, and confectionery industry production statistics.
  • Zero reliance on speculative third-party market research; all forecasts grounded in verifiable application dosage protocols, producer capacity benchmarks, and confirmed commercial developments.

The Food & Beverages end-user segment holds 48.7% of total market value in 2026, anchored by confectionery and bakery applications. Pharmaceuticals represents a defined growth vector as invertase serves oral dosage form sweetening and stability functions. Hypermarket and Supermarket distribution accounts for 35.4% of channel value in 2026 for commercial-scale ingredient procurement. Microorganism-based invertase holds 56.2% of source share, reflecting the commercial scalability of yeast-derived Saccharomyces cerevisiae fermentation for food-grade enzyme production. Plant-based invertase at 43.8% serves pharmaceutical-grade and specialty applications requiring non-microbial source certification.

Invertase Market Definition

The invertase market encompasses the global production, trade, and industrial application of invertase (beta-fructofuranosidase, EC 3.2.1.26), an enzyme that catalyzes the hydrolysis of sucrose into glucose and fructose, producing invert sugar. The market covers both microorganism-derived invertase from Saccharomyces cerevisiae yeast fermentation and plant-based invertase extracted from botanical sources, in liquid concentrate and powder forms. Primary commercial applications include soft-center chocolate confectionery production where sucrose crystallization is prevented, bakery moisture retention and texture management, invert sugar syrup production for confectionery and beverage sweetening, pharmaceutical oral dosage form taste modification, and personal care humectant applications.

Invertase Market Inclusions

The report includes comprehensive global and regional market sizing by volume and value with a 10-year forecast from 2026 to 2036. Segmental analysis covers source (Microorganisms-based, Plant-based), end-user (Food & Beverages, Pharmaceuticals, Personal Care), and distribution channel (Hypermarket/Supermarket, Convenience Store, Online). Application-specific activity unit benchmarks, pharmaceutical-grade source certification requirements, sugar reduction technology integration trends, and competitive positioning among major enzyme producers are incorporated.

Invertase Market Exclusions

The scope excludes invert sugar syrup as a finished sweetener commodity unless the invertase enzyme component is separately quantified. Sucrase supplements in clinical and therapeutic nutrition formulations for congenital sucrase-isomaltase deficiency treatment are outside the industrial enzyme market scope covered. Synthetic invertase mimics and non-enzymatic sucrose hydrolysis methods are excluded from market sizing, as are downstream finished confectionery and pharmaceutical products incorporating invertase as a processing aid.

Invertase Market Research Methodology

Primary Research:

Interviews were conducted with yeast-derived enzyme producers, confectionery and bakery formulation specialists specifying invertase in soft-center and moisture management applications, pharmaceutical oral dosage form developers, personal care ingredient formulators, and specialty enzyme distributors serving the food and pharmaceutical sectors.

Desk Research:

EU enzyme regulation data under Regulation (EC) No 1332/2008, FDA food additive GRAS notices for invertase, Saccharomyces cerevisiae fermentation capacity benchmarks from producer annual reports, confectionery industry production statistics, and pharmaceutical pharmacopoeia specifications for invertase in oral dosage applications supported the quantitative framework.

Market-Sizing and Forecasting:

A hybrid bottom-up and top-down model reconstructed demand from confectionery production volumes with soft-center application penetration rates, bakery enzyme usage benchmarks, pharmaceutical oral dosage form production statistics, and invert sugar syrup industrial demand data, validated against producer shipment data and known enzyme application dosage protocols.

Data Validation and Update Cycle:

Outputs underwent cross-validation against cocoa and sugar price-volume elasticity analysis for confectionery enzyme demand, pharmaceutical-grade certification requirement trends, anomaly screening, and expert review by confectionery technologists and enzyme application specialists prior to release.

Introduction

Complex molecules called enzymes to act as bio-catalysts in living tissue to improve metabolic processes. A carbohydrate enzyme that helps with digestion is invertase. Additionally known as beta-fructo-furanosidase. The Saccharomyces cerevisiae strain also referred to as baker's yeast is the source of invertase. Fructose and glucose are produced when sucrose is broken down into two parts with the help of invertase.

Once purified, it can be used alone or in conjunction with other enzymes. When combined, it facilitates the breakdown of starch, sugar, and other carbohydrate types. It is widely accessible from both plants and microorganisms. There are many uses for invertase.

It helps control osmosis and plant immune defenses in addition to helping humans have a better immune system and acting as an antioxidant. Additionally, because it is obtained naturally, using organic ingredients in meal preparation is a preferred option among meat producers.

Comparing historical outlook and projections for the world's Invertase

A new report published by Future market insights, titled, Invertase Market -Global Opportunity Analysis and Industry Forecast, 2025 to 2035, projects the global Invertase market to reach USD 97.5.0 million by 2035 and is expected to grow at a CAGR of 5.30% from 2025 to 2035.

Country-wise Insights

What is the outlook of Asia - Pacific in the market of Invertase in the world?

The Asia Pacific region offers a promising market for invertase since it provides an advantageous platform for studies and development. During the forecast timeframe, the Asia-Pacific bakery products market is expected to expand at a 6.6% CAGR. A burgeoning number of Western restaurants offering baked goods in metropolitan areas is also rapidly emerging, increasing demand for bakery products. This factor is expected to accelerate the expansion of the invertase market in this region.

Another significant driver of the market is a broader portfolio with several value-added products such as reduced sugar, enhanced nutrition, plant-based products, multiple distribution channels, and consumers' proclivity to buy off-the-shelf, particularly in this region's emerging markets.

What is the outlook of North America in the market of Invertase in the world?

Consumers prefer products that are naturally sourced, and since invertase is widely available in nature, industries in North America are using it to develop new food processing techniques.

Due to developments in food ingredients and technology, as well as rising regional consumption, the United States is anticipated to overwhelm the market in North America. The market is dominated by the United States, which is also driving the market's expansion in North America. With favorable annual growth during the forecast period, Canada is dominant due to the region's booming emerging economies and people's lifestyles. A market share of 38.0% of the worldwide invertase market is held by North America.

What is the outlook of Europe in the market of Invertase in the world?

The European invertase business has a well-developed supply chain, a wide range of products, effective distribution methods, and consumer preferences. Cakes, baked goods, and cookies are among the categories of decadence that have seen an increase in new innovation and product development.

The growth of the invertase industry in Europe, which would be cruising the expansion of the industry under consideration, is accelerated by rising consumer consciousness of health-conscious products and broadening demand for processed foods. Sales have increased as a result of several health claims related to bakery products, including organic, no flavorings, and low/no/reduced allergen. On the global invertase market, Europe has a 24.5% market share.

Category-wise Insights

What are the major drivers for Invertase in the Market?

Significant progress has been made in improving how different enzymes and their properties are operationally evaluated. The market for invertase is growing as a result. Invertase is widely utilized as a food ingredient and is frequently utilized as an invert sugar in the production of candy bars and commercial cooking due to its ability to retain humidity for extended periods of time.

It can be used to make a highly crystalline syrup, also known as inverted syrup because it is hygroscopic. Invertase also facilitates the acquisition of alcohols, glycerin, and lactic acid during the sucrose fermentation process. The business for invertase enzymes has seemed to be experiencing opportunistic growth as a result of rising customer demands novel solutions, particularly in the industries of food and beverages.

Additionally, invertase is used to improve digestion, boost the immune system, support antioxidants, and fight cancer. Invertase can also function in a variety of pH conditions. Its relevance to the pharmaceutical sector thus expands. As a result, numerous uses contribute to the invertase market's fast expansion.

What are the restraints of different types of Invertase?

The invertase enzyme, on the other hand, can cause vomiting, diarrhea, and fatigue. Additionally, it may lead to diabetes, so invertase-containing products are not advised for diabetic patients.

As a result, in areas where the prevalence of diabetes is high, the growth of invertase sales may be constrained. Enzyme coupling is also fairly expensive. As a result, its applicability to various industries may decline, which would restrain the market's growth for invertase.

Major segmentized utilization of Invertase

It can be discovered in many personal care items, such as hair products, shampoos, hair dyes, as well as styling products. Additionally, invertase is found in beauty products to help break down dry skin and hasten cell turnover. Cosmetics contain invertase as a food preservation and fragrance component. The products for the personal care market are anticipated to experience significant demand as a result of the expansion in the invertase sector.

Plant invertase is a renowned class of enzymes that catalyzes the conversion of sucrose into glucose and fructose. They have been found in numerous plant tissues and are important for the growth and metabolism of plants. In the upcoming years, it is anticipated that the plant invertase market will grow.

Supermarket and Industrial Distributors Are Propelling the Growth Invertase in Market

The Invertase in the market is expected to grow at a CAGR of 5.30% during the forecast period of 2025 to 2035. The growth of Invertase in the market is being propelled by supermarket and industrial distributors.

It is a natural enzyme that is used as a food ingredient to sweeten food items, as well as for other applications such as brewing beer. Invertase has seen an increase in demand due to its wide range of uses and its ability to be tailored to suit various needs. Supermarkets and industrial distributors are helping this growth by making it more accessible across the world.

Supermarket and industrial distributors have been introducing Invertase into their product portfolios, allowing customers greater access than ever before. Furthermore, these distributors are offering Invertase at competitive prices so that companies can purchase it with ease. This has resulted in increased availability of the enzyme for both commercial use and home cooking alike.

Competitive Landscape

The invertase market is moderately fragmented with a combination of large diversified enzyme producers and specialty distributors. Koninklijke DSM N.V. holds an estimated 14.1% share in 2026, with Sigma-Aldrich (Merck), SternEnzym GmbH, Kerry Inc., Parchem Fine & Specialty Chemicals, MP Biomedicals, BIO-CAT, Megazyme, and Meteoric Exim as regional competitors. The Novonesis formation through the Novozymes and Chr. Hansen merger has concentrated specialty enzyme R&D and distribution capacity, with the subsequent acquisition of dsm-firmenich's feed enzyme alliance further consolidating industrial enzyme supply chain control under a single entity with greater scale for specialty categories. [1]

BASF and IFF's October 2025 partnership to advance Designed Enzymatic Biomaterials technology is a forward-looking competitive investment that targets next-generation enzyme performance rather than current commodity invertase supply, but its commercial outputs from 2027 onward will progressively raise the performance baseline expected by food and pharmaceutical buyers. [2] Kerry Group's February 2026 Tastesense breakthrough enzyme system launch bundles invertase-class enzymes within sugar reduction solutions that compete for formulation budgets on a systemic basis rather than a per-enzyme ingredient basis, meaning specialty enzyme distributors not embedded in Kerry's supply chain may face margin compression as food manufacturers consolidate enzyme sourcing through integrated sugar management partnerships. [3]

Buyer leverage in food-grade invertase is moderate, with a defined supplier pool and established application protocols limiting aggressive price negotiation. Pharmaceutical-grade invertase buyers face a constrained certified supplier pool with higher switching costs due to source qualification requirements.

Recent Developments

• October 2025: BASF and IFF announced a major strategic partnership to accelerate the development of IFF's Designed Enzymatic Biomaterials technology platform. The collaboration combines BASF's chemical production expertise with IFF's biotechnology and protein engineering capabilities, aiming to deliver breakthrough enzyme systems at commercial scale with enhanced performance and sustainability across several industrial sectors including food enzyme applications. [1]
• June 2025: Following the merger of Novozymes and Chr. Hansen into Novonesis, the company completed the acquisition of dsm-firmenich's stake in their long-standing Feed Enzyme Alliance. By 2026, Novonesis fully integrated these sales and distribution activities with its R&D and innovation arms, allowing it to operate as a biosolutions player controlling the full enzyme production and distribution value chain for specialty categories including invertase. [2]
• February 2026: Kerry Group announced the launch of a breakthrough enzyme system as part of its Tastesense sweet reduction technologies, using fermentation-derived enzymes designed to preserve taste profiles while significantly reducing sugar and raw material dependence. This development addresses cocoa and sugar price volatility in the confectionery and bakery markets where invertase is a primary component for moisture retention and texture management. [3]

Key Players in Invertase Market

• Koninklijke DSM N.V.
• Sigma-Aldrich Co. LLC.
• Parchem Fine & Specialty Chemicals
• SternEnzym GmbH & Co. KG
• Kerry Inc.
• Meteoric Exim Private Limited
• MP Biomedicals LLC
• BIO-CAT
• Megazyme Inc.
• Fidopharma

Invertase Market Report Scope

Metric	Value
Quantitative Units	USD 67.9 million (2026) to USD 101.4 million (2036), at a CAGR of 4.1%
Market Definition	The invertase market covers global production and trade of microorganism-based and plant-based invertase enzyme for sucrose hydrolysis applications in confectionery soft-center production, bakery moisture management, pharmaceutical oral dosage taste modification, and personal care humectant applications.
Source Segmentation	Microorganisms-based Invertase, Plant-based Invertase
End-User Segmentation	Food & Beverages, Pharmaceuticals, Personal Care
Distribution Channel Segmentation	Hypermarket/Supermarket, Convenience Store, Online
Regions Covered	North America, Latin America, Europe, East Asia, South Asia, Oceania, Middle East and Africa
Countries Covered	United States, Germany, France, United Kingdom, China, Japan, India, Brazil, Australia, Canada and 40 plus countries
Key Companies Profiled	Koninklijke DSM N.V., Sigma-Aldrich Co. LLC., Parchem Fine & Specialty Chemicals, SternEnzym GmbH & Co. KG, Kerry Inc., Meteoric Exim Private Limited, MP Biomedicals LLC, BIO-CAT, Megazyme Inc., Fidopharma
Forecast Period	2026 to 2036
Approach	Hybrid bottom-up and top-down market modeling validated through primary interviews with yeast-derived enzyme producers and confectionery formulation specialists, supported by EU Regulation EC No 1332/2008 enzyme framework data and FDA GRAS notices for invertase

Invertase Market is segmentation

Source

• Microorganisms-based Invertase (56.2% share, 2026)
• Plant-based Invertase

End-User

• Food & Beverages (48.7% share, 2026)
• Pharmaceuticals
• Personal Care

Distribution Channel

• Hypermarket/Supermarket (35.4% share, 2026)
• Convenience Store
• Online

Region

• North America: United States (USD 25.5M, 2026), Canada, Mexico
• Latin America: Brazil, Argentina, Chile, Rest of Latin America
• Europe: Germany, France, United Kingdom, Italy, Spain, Benelux, Nordics, Rest of Europe
• East Asia: China, Japan (USD 53.3M projected, 2036), South Korea
• South Asia: India, Indonesia, Malaysia, Thailand, Rest of South Asia
• Oceania: Australia, New Zealand
• Middle East & Africa: Saudi Arabia, UAE, South Africa, Rest of Middle East & Africa

 

Bibliography

• [1] BASF SE. (2025). BASF and IFF Announce Strategic Partnership to Accelerate Designed Enzymatic Biomaterials Technology Platform. Corporate Press Release, October 2025. https://www.basf.com/global/en/media/news-releases/2025/10/p-25-207
• [2] Novonesis. (2025). Novonesis Acquires DSM-Firmenich's Share in Feed Enzyme Alliance. Corporate Press Release, June 2025. https://www.novonesis.com/en
• [3] Food Ingredients First. (2026). Kerry Group Announces Breakthrough Enzyme System in Tastesense Sweet Reduction Technologies. Industry Report, February 2026. https://www.foodingredientsfirst.com/news/kerry-taste-innovation-fy2025-margin.html
• [4] Nutritional Outlook. (2025). Amano Enzyme USA Highlights Enzyme Innovation Offerings at SupplySide Global 2025. Trade Report, 2025. https://www.nutritionaloutlook.com/view/amano-enzyme-usa-highlights-enzyme-innovation-offerings-at-supplyside-global-2025
• [5] Chemicals Knowledge Hub. (2025). SEQENS and APPLEXION Announce Strategic Partnership for Distribution of SEQENZYM FT. Industry News, 2025. https://www.chemicalsknowledgehub.com/news/seqens-and-applexion-announce-strategic-partnership-for-the-distribution-of-seqenzym-ft/

This Report Addresses

• Market intelligence to enable invertase sourcing strategy and application development decisions across confectionery, bakery, pharmaceutical, and personal care end-user segments
• Market size estimation and 10-year revenue forecasts from 2026 to 2036, supported by confectionery production volume benchmarks and pharmaceutical oral dosage form demand data
• Growth opportunity mapping across microorganism-based and plant-based source categories with emphasis on pharmaceutical-grade certification pathways and sugar reduction system integration
• Segment and regional revenue forecasts covering source, end-user, and distribution channel dimensions across key consuming markets
• Competition strategy assessment including Novonesis consolidation impact, Kerry Tastesense bundled enzyme system competitive implications, and BASF-IFF engineered enzyme platform development monitoring
• Supply chain analysis covering Saccharomyces cerevisiae fermentation capacity, pharmaceutical-grade plant-based source qualification requirements, and specialty distributor positioning in a consolidating enzyme supply landscape
• Regulatory impact analysis covering EU Regulation EC No 1332/2008 enzyme approval framework, FDA GRAS notices, and pharmaceutical pharmacopoeia specification compliance requirements
• Market report delivery in PDF, Excel, PPT, and interactive dashboard formats for executive and operational use